News

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.
In the early 2000s the U.S. Diabetes Prevention Program (DPP), a large randomized clinical trial, showed that intensive lifestyle modification was ...
Rapamycin may match the benefits of eating less. Scientists are now exploring its potential to support healthy aging. The ...
Caffeine activates cell survival pathways in yeast, potentially slowing aging through energy and stress responses.
A massive analysis recently published in the journal Aging Cell revealed that rapamycin — the immunosuppressant drug turned ...
Metformin should not be used to treat type 1 diabetes. “I cannot stress enough that metformin is not a primary weight loss medication,” adds Dr. Schmidt.
Turmeric : The dried and ground rhizome (the underground stem) of the Curcuma longa plant. It is a bright yellow-orange spice ...
Dr. Ambish Mithal unpacks the world of new-age weight management drugs, their side effects, their benefits and what lies ...
Generative AI's potential to bolster business is staggering. According to one 2023 estimate from McKinsey, in the coming ...
Caffeine has long been linked to potential health benefits, including reduced risk of age-related diseases.
That energising cup of coffee you rely on each morning may be doing more than just waking you up. A new study from the Queen ...
Various foods, such as berries, whole grains, fish, milk, and some plant-based options, have shown anti-diabetic effects in studies. These foods are rich in bioactive compounds that may assist in ...